Stifel Financial Corp Invests $337,000 in SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH)

Stifel Financial Corp purchased a new position in SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm purchased 7,607 shares of the company’s stock, valued at approximately $337,000. Stifel Financial Corp owned 0.16% of SPDR S&P Pharmaceuticals ETF at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. BNP Paribas Financial Markets raised its position in SPDR S&P Pharmaceuticals ETF by 208.6% during the 3rd quarter. BNP Paribas Financial Markets now owns 149,419 shares of the company’s stock valued at $6,628,000 after purchasing an additional 101,000 shares in the last quarter. First Citizens Bank & Trust Co. increased its stake in shares of SPDR S&P Pharmaceuticals ETF by 9.5% during the third quarter. First Citizens Bank & Trust Co. now owns 72,053 shares of the company’s stock valued at $3,196,000 after buying an additional 6,227 shares during the period. AlphaMark Advisors LLC raised its holdings in shares of SPDR S&P Pharmaceuticals ETF by 5.9% in the third quarter. AlphaMark Advisors LLC now owns 6,225 shares of the company’s stock valued at $276,000 after acquiring an additional 348 shares in the last quarter. Rockport Wealth LLC purchased a new stake in SPDR S&P Pharmaceuticals ETF in the second quarter worth about $1,813,000. Finally, Angeles Wealth Management LLC bought a new position in SPDR S&P Pharmaceuticals ETF during the 2nd quarter worth about $40,000.

SPDR S&P Pharmaceuticals ETF Stock Performance

NYSEARCA XPH opened at $43.49 on Friday. SPDR S&P Pharmaceuticals ETF has a one year low of $38.88 and a one year high of $48.76. The company has a market capitalization of $210.93 million, a price-to-earnings ratio of 14.39 and a beta of 0.87. The company’s 50-day simple moving average is $45.65 and its two-hundred day simple moving average is $43.77.

SPDR S&P Pharmaceuticals ETF Profile

SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.